Clinical Trial Update: Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating capecitabine after surgery versus observation in biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 3 | Status: COMPLETED